Agile Bioanalytical Services CRO

• Expertise
  • All Expertise
  • Mass Spectrometry (LC-MS)
    • Mass Spectrometry Services
    • HPLC Testing Services
  • ELISA Assay
    • Meso Scale Discovery Assay
    • Luminex Multiplex Assay
  • Flow Cytometry
  • qPCR Analysis, ddPCR Assay
  • Western Blot, In Cell Western
• Services
  • All Services
  • Pharmacokinetics (PK) Study
    • Toxicology (Tox) Study
    • Dose Formulation Analysis
    • PK PD Analysis
    • Drug Metabolism and Pharmacokinetics (DMPK)
    • ADME Studies
    • Bioequivalence and Bioavailability Studies
  • ADA Assay, Neutralizing Antibody Assay
  • Multiplex Cytokine Assay
  • Biomarker Assay
    • Biomarker Assay List
  • Cell-Based Assay
    • Mechanism of Action (MOA) Studies
    • Cytotoxicity Assay
    • Biochemical Assay
  • Bioanalytical Assay Validation
• Solutions
  • All Solutions
  • Clinical CRO
    • Central Lab Services
    • PBMC Services
  • GLP Laboratory
    • Bioanalysis
    • Non-GLP Testing
  • Preclinical CRO
  • Method Development, Validation, And Transfer
    • Method Validation
    • Method Development
    • Method Transfer
  • Analytical Testing
    • Discovery Screening Services
    • Analytical Quantitation
    • Cosmetic Testing
• About Us
  • About Us
  • Overview
  • Leadership
  • Facility and Equipment
  • Quality and Compliance
  • Therapeutic Areas
  • Why Us?
  • Values
  • Process
  • Partners
  • Careers
    • Sr. Scientist – Cell Based Assay
    • Associate Scientist, Central Laboratory Services
    • Business Development Associate
    • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
    • Sr. Scientist, ELISA Immunoassay Bioanalysis – Hamden, CT, USA
    • GLP Quality Assurance Manager
    • Sr. Scientist - Pharmacokinetics (PK)
    • Content Manager, Scientific and Regulatory Writing
• Resources
  • Learning Center
  • Blog
  • Case Study
  • Video Brochures
  • News and Events
  • Testimonials
  • Contact Us
• Request Quote

Agile Bioanalytical Services CRO Request Quote

• Home
• FDA Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals (1997)

FDA S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals (1997)